Not applicableApproved For MarketingNCT04256265
What this trial is testing
An Expanded Access Program for Risdiplam in Participants With Spinal Muscular Atrophy (SMA)
Who this might be right for
Muscular Atrophy, Spinal
Genentech, Inc.
Showing 20 of 59 results